Traditional Rehabilitation Versus Rehabilitation With the Imoove® Device for Spinal Musculoskeletal Disorders (IMOOVE IT)

Traditional Rehabilitation Versus Rehabilitation With the Imoove® Device for Spinal Musculoskeletal Disorders: a Randomised Controlled Trial

The main objective of this study is to evaluate in patients with chronic low back pain (lasting for more than 3 months and not postoperative) the effect of an instrumental rehabilitation using the I-Moove ® device compared to a conventional physiotherapy rehabilitation for ambulatory postural stability (mean and standard deviation of excursions from the center of gravity) without visual control, 6 weeks after the start of the rehabilitation protocol. We focus on the relative variation between the values obtained on day 0 versus 6 weeks, via measures performed on a force platform. The results will be stratified into 3 age groups (18-39 years, 40-60 years and over 60 years).

Study Overview

Detailed Description

The secondary objectives of this study are to evaluate and compare the two physical therapy techniques at 6 weeks and 6 months after the start of the rehabilitation protocol in terms of:

A - improving postural stability and visual control on an unstable surface (with and without visual control)

B - improving levels of abdominal strength (Ito test) and erector spinae (Sørensen test)

C - the impact of back pain on daily life using questionnaires (Dallas, Québec, FABQ and Tampa questionnaires/scores)

D - Improvement of pain (Visual Analog Scale),

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • CHRU de Montpellier - Hôpital Lapeyronie
      • Nîmes Cedex 9, France, 30029
        • CHRU de Nîmes - Hôpital Universitaire Carémeau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 6 months of follow-up
  • Patients with pain in the lumbar spine (low back pain) for at least 3 months, not in connection with an operation

Exclusion Criteria:

  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient will have difficulties with follow-up (the patient is about to move, or isn't motivated)
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient, or breastfeeding
  • The patient has already participated in a dynamic physical therapy program
  • The patient has a contraindication for a treatment used in this study
  • The patient has had surgery in the past year
  • The patient has a pathology that can interfere with the physical therapy regimen (heart failure, respiratory failure, major orthopedic problems)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Routine Physical Therapy

Patients randomized to this arm will follow a classic, routine, physical therapy program.

Intervention: Routine Physical Therapy

Patients randomized to this arm will participate in a classic physical therapy program (15 weeks, a total of 15 sessions).
Experimental: I-Moove Physical Therapy

Patients randomized to this arm will follow a physical therapy program using the I-Moove device.

Intervention: I-Moove Physical Therapy

Patients randomized to this arm will participate in a physical therapy program using the I-Moove device (15 weeks, a total of 15 sessions).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in postural stability on the platform, eyes closed
Time Frame: Baseline to 6 weeks
Baseline to 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in postural stability on the platform, eyes closed
Time Frame: Baseline to 6 months
Baseline to 6 months
Change in postural stability on the platform, eyes open
Time Frame: Baseline to 6 weeks
Baseline to 6 weeks
Change in postural stability on the platform, eyes open
Time Frame: Baseline to 6 months
Baseline to 6 months
Change in postural stability on the platform, eyes open and with an unstable surface
Time Frame: Baseline to 6 weeks
Baseline to 6 weeks
Change in postural stability on the platform, eyes open and with an unstable surface
Time Frame: Baseline to 6 months
Baseline to 6 months
Change in postural stability on the platform, eyes closed and with an unstable surface
Time Frame: Baseline to 6 weeks
Baseline to 6 weeks
Change in postural stability on the platform, eyes closed and with an unstable surface
Time Frame: Baseline to 6 months
Baseline to 6 months
Abdominal endurance: Ito test
Time Frame: Baseline (day 0)
Baseline (day 0)
Abdominal endurance: Ito test
Time Frame: 6 weeks
6 weeks
Abdominal endurance: Ito test
Time Frame: 6 months
6 months
Sorensen test
Time Frame: Baseline (day 0)
Baseline (day 0)
Sorensen test
Time Frame: 6 weeks
6 weeks
Sorensen test
Time Frame: 6 months
6 months
Dallas questionnaire
Time Frame: Baseline (day 0)
Baseline (day 0)
Dallas questionnaire
Time Frame: 6 weeks
6 weeks
Dallas questionnaire
Time Frame: 6 months
6 months
Quebec questionnaire
Time Frame: Baseline (day 0)
Baseline (day 0)
Quebec questionnaire
Time Frame: 6 weeks
6 weeks
Quebec questionnaire
Time Frame: 6 months
6 months
FABQ questionnaire
Time Frame: Baseline (day 0)
Baseline (day 0)
FABQ questionnaire
Time Frame: 6 weeks
6 weeks
FABQ questionnaire
Time Frame: 6 months
6 months
Tampa Score
Time Frame: Baseline (day 0)
Baseline (day 0)
Tampa Score
Time Frame: 6 weeks
6 weeks
Tampa Score
Time Frame: 6 months
6 months
Visual analog scale for pain
Time Frame: Baseline (day 0)
ranging from 0 to 10
Baseline (day 0)
Visual analog scale for pain
Time Frame: 6 weeks
ranging from 0 to 10
6 weeks
Visual analog scale for pain
Time Frame: 6 months
ranging from 0 to 10
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Arnaud Dupeyron, MD, PhD, Centre Hospitalier Universitaire de Nīmes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 4, 2014

Primary Completion (Actual)

June 28, 2018

Study Completion (Actual)

June 28, 2018

Study Registration Dates

First Submitted

April 15, 2014

First Submitted That Met QC Criteria

April 15, 2014

First Posted (Estimate)

April 16, 2014

Study Record Updates

Last Update Posted (Actual)

July 5, 2019

Last Update Submitted That Met QC Criteria

July 3, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • AOI/2012/AD-01
  • 2013-A00743-42 (Other Identifier: RCB number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Back Pain

Clinical Trials on Routine Physical Therapy

Subscribe